Search

everythinglearnresearchcommunity

for

Search:↓

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Post-COVID conditions increase health care needs for six months after infection.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Mutations in the spike protein affect drug binding and effectiveness.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

COVID-19 infection may trigger alopecia areata in some patients.

Sarcoptic mange nearly wiped out vicuñas and guanacos in an Argentine park.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

A woman's sudden hair loss was linked to her previous COVID-19 infection.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Sargassum muticum extract and its component apo-9'-fucoxanthinone may help hair growth and treat hair loss.

Amitraz effectively treated sarcoptic mange in three alpacas.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

COVID-19 and its vaccines can cause hair loss, which is not serious and can improve with psychological support.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.